Brightworth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4.95M Buy
9,763
+362
+4% +$203K 0.53% 39
2022
Q2
$5.11M Buy
9,401
+280
+3% +$154K 0.55% 40
2022
Q1
$5.39M Buy
+9,121
New +$5.24M 0.55% 38
2018
Q2
Sell
-1,080
Closed -$223K 129
2018
Q1
$223K Sell
1,080
-116
-10% -$24.3K 0.05% 109
2017
Q4
$227K Hold
1,196
0.05% 108
2017
Q3
$226K Hold
1,196
0.05% 114
2017
Q2
$209K Buy
+1,196
New +$201K 0.12% 34

Other funds holding TMO

Brightworth's TMO Position: Q3 2022 in Review

Brightworth increased its Thermo Fisher Scientific (TMO) stake by 3.9% in Q3 2022, buying an estimated $203K and bringing the position to 9,763 shares worth $4.95M. The position accounts for 0.53% of the portfolio, ranked #39.

Brightworth first reported a position in TMO in Q2 2017 and has held it in 7 quarters since. The position peaked at $5.39M in Q1 2022. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • Brightworth held 9,763 shares of Thermo Fisher Scientific worth $4.95M as of Q3 2022.
  • Brightworth bought 362 Thermo Fisher Scientific shares in Q3 2022, an estimated $203K.
  • Thermo Fisher Scientific made up 0.53% of Brightworth's portfolio in Q3 2022, its #39 holding.
  • Brightworth first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 7 quarters since.
  • Brightworth's Thermo Fisher Scientific position peaked at $5.39M in Q1 2022.
  • 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Brightworth's 13F filing for Q3 2022, filed 28 Oct 2022.